Raphas Co., Ltd. (KOSDAQ:214260)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,390
-480 (-2.85%)
At close: Apr 25, 2025, 3:30 PM KST
20.60%
Market Cap 137.81B
Revenue (ttm) 27.22B
Net Income (ttm) -4.77B
Shares Out 8.41M
EPS (ttm) -544.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 53,454
Average Volume 73,717
Open 17,340
Previous Close 16,870
Day's Range 16,100 - 17,340
52-Week Range 9,300 - 31,500
Beta 1.26
RSI 60.71
Earnings Date May 14, 2025

About Raphas

Raphas Co., Ltd. manufactures and sells biodegradable microneedles in Korea. The company offers skin care, medical device, whitening care, and wrinkle care under the Acropass brand; and health food product under the FitKong brand. It also supplies double-layer microneedle manufacturing technology; and provides original development manufacturing, and contract development and manufacturing organization services. The company was founded in 2006 and is headquartered in Seoul, South Korea. [Read more]

Industry Perfumes, Cosmetics, and Other Toilet Preparations
Founded 2006
Employees 77
Stock Exchange KOSDAQ
Ticker Symbol 214260
Full Company Profile

Financial Performance

In 2024, Raphas's revenue was 27.22 billion, a decrease of -2.58% compared to the previous year's 27.94 billion. Losses were -4.77 billion, -45.80% less than in 2023.

Financial Statements

News

There is no news available yet.